NCT04472819View on ClinicalTrials.gov

The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions

Thrombosis

Interventions

DRUG

SHR2285 tablet

single dose or multi-dose

DRUG

Placebo

single dose or multi-dose

Trial Locations (2)

100034

Peking University First Hospital, Beijing

410006

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04472819 - The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Healthy Subjects | Biotech Hunter | Biotech Hunter